Arcus Biosciences, Inc. (RCUS)
USD 15.17
(-5.66%)
USD 15.17
(-5.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 117 Million | 112 Million | 382.88 Million | 77.51 Million | 15 Million | 8.35 Million |
| Cost of Revenue | 340 Million | 14 Million | 7.05 Million | 159 Million | 78.48 Million | 49.64 Million |
| Gross Profit | -223 Million | 98 Million | 375.82 Million | -81.48 Million | -63.48 Million | -41.29 Million |
| Operating Expenses | 457 Million | 392 Million | 328.63 Million | 201.75 Million | 103.7 Million | 63.21 Million |
| Selling, General and Administrative Expenses | 117 Million | 104 Million | 72.28 Million | 42.4 Million | 25.22 Million | 13.56 Million |
| Research and Development Expenses | 340 Million | 288 Million | 256.34 Million | 159.34 Million | 78.48 Million | 49.64 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 457 Million | 392 Million | 328.63 Million | 201.75 Million | 103.7 Million | 63.21 Million |
| Operating Income | -340 Million | -280 Million | 54.24 Million | -124.23 Million | -88.7 Million | -54.85 Million |
| Interest Expense | 2 Million | 2 Million | 260 Thousand | - | - | 4.92 Million |
| Income Tax Expense | 6 Million | 1 Million | 1.81 Million | -6.18 Million | -8.77 Million | 5.26 Million |
| Earnings before Tax | -301 Million | -266 Million | 54.64 Million | -122.85 Million | -84.71 Million | -49.59 Million |
| Net Income | -307 Million | -267 Million | 53 Million | -116.67 Million | -75.93 Million | -49.59 Million |
| Earnings Per Share Basic | -4.15 | -3.71 | 0.76 | -2.13 | -1.73 | -1.43 |
| Earnings Per Share Diluted | -4.15 | -3.71 | 0.71 | -2.13 | -1.73 | -1.43 |
| Weighted Average Shares Outstanding | 74 Million | 72 Million | 69.34 Million | 54.78 Million | 43.82 Million | 34.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 74 Million | 72 Million | 73.96 Million | 54.78 Million | 43.82 Million | 34.61 Million |
| Gross Margin | -1.91 | 0.88 | 0.98 | -1.05 | -4.23 | -4.94 |
| EBIT Margin | -2.42 | -2.36 | 0.14 | -1.61 | -5.91 | -6.71 |
| Profit Margin | -2.62 | -2.38 | 0.14 | -1.51 | -5.06 | -5.94 |
| EBITDA | -283 Million | -250 Million | 61.96 Million | -118.46 Million | -81.13 Million | -51.19 Million |
| Earnings Before Tax Margin | -2.91 | -2.50 | 0.14 | -1.60 | -5.91 | -6.57 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 39 Million | 145 Million | 31 Million | 117 Million | 32 Million | 29 Million |
| Cost of Revenue | 2 Million | 3 Million | 5 Million | 16 Million | 3 Million | 4 Million |
| Gross Profit | 37 Million | 142 Million | 26 Million | 101 Million | 29 Million | 25 Million |
| Operating Expenses | 143 Million | 141 Million | 122 Million | 457 Million | 112 Million | 112 Million |
| Selling, General and Administrative Expenses | 28 Million | 32 Million | 29 Million | - | 30 Million | 28 Million |
| Research and Development Expenses | 115 Million | 109 Million | 93 Million | - | 82 Million | 84 Million |
| Other Expenses | - | 20 Million | - | - | - | - |
| Cost and Expenses | 145 Million | 141 Million | 122 Million | 457 Million | 112 Million | 112 Million |
| Operating Income | -106 Million | -16 Million | -91 Million | -340 Million | -80 Million | -83 Million |
| Interest Expense | - | 1 Million | -2 Million | 2 Million | 1 Million | - |
| Income Tax Expense | - | 1 Million | 1 Million | 6 Million | 2 Million | 1 Million |
| Earnings before Tax | -93 Million | -4 Million | -80 Million | -301 Million | -69 Million | -74 Million |
| Net Income | -93 Million | -4 Million | -81 Million | -307 Million | -71 Million | -75 Million |
| Earnings Per Share Basic | -1.02 | -0.05 | -1.08 | - | -0.95 | -1.02 |
| Earnings Per Share Diluted | -1.02 | -0.05 | -1.08 | - | -0.95 | -1.02 |
| Weighted Average Shares Outstanding | 91.1 Million | 86.2 Million | 75 Million | 74 Million | 74.6 Million | 73.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.1 Million | 86.2 Million | 75 Million | 74 Million | 74.6 Million | 73.2 Million |
| Gross Margin | 0.95 | 0.98 | 0.84 | 0.86 | 0.91 | 0.86 |
| EBIT Margin | -2.67 | 0.14 | -2.48 | - | -2.12 | -2.55 |
| Profit Margin | -2.38 | -0.03 | -2.61 | -2.62 | -2.22 | -2.59 |
| EBITDA | -104 Million | 20 Million | -77 Million | - | -68 Million | -74 Million |
| Earnings Before Tax Margin | -2.72 | -0.11 | -2.94 | -2.91 | -2.50 | -2.86 |
FFXXF
0RT6
4806
EBEN
RERE
CCL